Updates are available Correction dated 2024-02-12
Click to view Correction: https://doi.org/10.1007/s41669-024-00475-w
-
Authors
Rossini, Elvio Emanuele http://orcid.org/0000-0003-3928-8550
Galeone, Carlotta
Lucchetti, Chiara
Jommi, Claudio
- License Information
-
More Information
Article History
Accepted: 14 December 2023
First Online: 16 January 2024
Change Date: 12 February 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s41669-024-00475-w
Declarations
:
: This research received no external funding and the Working Group has not received any funds. Pharmalex Italy S.P.A. funded the article processing charge.
: Claudio Jommi reports serving as an advisory board member and a paid speaker for Amgen, AstraZeneca, BMS, CSL Behring, Gilead, Incyte, MSD, Roche, Sanofi, and Takeda, outside the submitted work. Elvio Rossini, Carlotta Galeone and Chiara Lucchetti have no affiliations with, or involvement in, any organization or entity with any financial or non-financial interest in the subject matter or materials discussed in this manuscript.
: The datasets generated and analyzed during the current study are not publicly available for confidentiality reasons but are available from the corresponding author on reasonable request.
: Conceptualization: EER, CG, CL, CJ. Data curation: EER. Formal analysis: EER, CG. Investigation: EER, CG, CJ. Methodology: EER, CG, CL, CJ. Project administration: CJ. SupEERvision: CJ. Validation: EER, CG, CL, CJ. Writing – original draft: EER, CG, CL, CJ. Writing – review and editing: EER, CJ.
: Not applicable.
: Not applicable.
: Not applicable.
: Due to the sensitive nature of the data involved in this study, which includes confidential drug pricing information, we regret that we are unable to share the raw data used in our analysis publicly. Our primary concern is to protect the confidentiality and integrity of this proprietary pricing data while avoiding cross-reference pricing between countries. However, we are committed to providing aggregated and anonymized findings, summary statistics, and the methodology used in this research to ensure transparency to the fullest extent possible, while adhering to data privacy and legal restrictions. Researchers interested in accessing the summarized results or replicating the analysis are encouraged to contact the corresponding author for further collaboration and discussion.
